SCHRODER INVESTMENT MANAGEMENT GROUP - TAKEDA PHARMACEUTICAL CO LTD ownership

TAKEDA PHARMACEUTICAL CO LTD's ticker is TAK and the CUSIP is 874060205. A total of 311 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q4 2020. The put-call ratio across all filers is 1.03 and the average weighting 0.2%.

Quarter-by-quarter ownership
SCHRODER INVESTMENT MANAGEMENT GROUP ownership history of TAKEDA PHARMACEUTICAL CO LTD
ValueSharesWeighting
Q1 2021$135,000
-50.0%
7,366
-50.1%
0.00%
Q4 2020$270,000
-47.3%
14,760
-50.5%
0.00%
-100.0%
Q3 2020$512,000
+2460.0%
29,836
+2627.2%
0.00%
Q2 2020$20,000
+17.6%
1,0940.0%0.00%
Q1 2020$17,000
-22.7%
1,0940.0%0.00%
Q4 2019$22,000
-62.7%
1,094
-67.7%
0.00%
Q3 2019$59,000
-21.3%
3,389
-20.5%
0.00%
Q2 2019$75,000
-13.8%
4,2640.0%0.00%
Q1 2019$87,0004,2640.00%
Other shareholders
TAKEDA PHARMACEUTICAL CO LTD shareholders Q4 2020
NameSharesValueWeighting ↓
TFG Asset Management GP Ltd 1,903,662$29,449,6525.37%
MANAGED ASSET PORTFOLIOS, LLC 1,736,416$26,862,3564.12%
Y.D. More Investments Ltd 1,381,550$21,372,5794.11%
Clean Yield Group 533,157$8,167,9653.62%
XY Capital Ltd 143,697$2,222,9931.28%
Mondrian Investment Partners LTD 4,081,715$61,225,7251.26%
Capricorn Fund Managers Ltd 204,892$3,169,6791.10%
Legacy Wealth Asset Management, LLC 124,967$1,933,2390.71%
HAP Trading, LLC 263,679$4,079,1140.65%
BRANDES INVESTMENT PARTNERS, LP 1,802,036$27,877,4930.54%
View complete list of TAKEDA PHARMACEUTICAL CO LTD shareholders